Rovina Ruslami
Rovina Ruslami
Professor in clinical pharmacology, Universitas Padjadjaran
Verified email at
Cited by
Cited by
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
R Ruslami, AR Ganiem, S Dian, L Apriani, TH Achmad, AJ van der Ven, ...
The Lancet infectious diseases 13 (1), 27-35, 2013
Implications of the global increase of diabetes for tuberculosis control and patient care
R Ruslami, RE Aarnoutse, B Alisjahbana, AJAM Van Der Ven, ...
Tropical Medicine & International Health 15 (11), 1289-1299, 2010
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes
HMJ Nijland, R Ruslami, JE Stalenhoef, EJ Nelwan, B Alisjahbana, ...
Clinical Infectious Diseases 43 (7), 848-854, 2006
Intensified antituberculosis therapy in adults with tuberculous meningitis
AD Heemskerk, ND Bang, NTH Mai, TTH Chau, NH Phu, PP Loc, ...
New England Journal of Medicine 374 (2), 124-134, 2016
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients
R Ruslami, HMJ Nijland, B Alisjahbana, I Parwati, R van Crevel, ...
Antimicrobial agents and chemotherapy 51 (7), 2546-2551, 2007
Rifampicin reduces plasma concentrations 281 of moxifloxacin in patients with tuberculosis
HJ Nijland, R Ruslami, AJ Suroto, DM Burger, B Alisjahbana
Clin. Infect. Dis 45, 1001-1007, 0
Clinical management of concurrent diabetes and tuberculosis and the implications for patient services
AL Riza, F Pearson, C Ugarte-Gil, B Alisjahbana, S van de Vijver, ...
The lancet Diabetes & endocrinology 2 (9), 740-753, 2014
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes
R Ruslami, HMJ Nijland, IGN Adhiarta, SHKS Kariadi, B Alisjahbana, ...
Antimicrobial agents and chemotherapy 54 (3), 1068-1074, 2010
Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults
D Menzies, M Adjobimey, R Ruslami, A Trajman, O Sow, H Kim, ...
New England Journal of Medicine 379 (5), 440-453, 2018
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients
E Burhan, C Ruesen, R Ruslami, A Ginanjar, H Mangunnegoro, ...
Antimicrobial agents and chemotherapy 57 (8), 3614-3619, 2013
Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis
L te Brake, S Dian, AR Ganiem, C Ruesen, D Burger, R Donders, ...
International journal of antimicrobial agents 45 (5), 496-503, 2015
GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last
NC Bahr, S Marais, M Caws, R Van Crevel, RJ Wilkinson, JS Tyagi, ...
Clinical Infectious Diseases 62 (9), 1133-1135, 2016
Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia
A van Laarhoven, S Dian, C Ruesen, E Hayati, MSMA Damen, J Annisa, ...
The Journal of infectious diseases 215 (7), 1029-1039, 2017
Safety and side effects of rifampin versus isoniazid in children
T Diallo, M Adjobimey, R Ruslami, A Trajman, O Sow, J Obeng Baah, ...
New England Journal of Medicine 379 (5), 454-463, 2018
TANDEM: understanding diabetes and tuberculosis
R van Crevel, HM Dockrell
The lancet Diabetes & endocrinology 2 (4), 270-272, 2014
S2k-Leitlinie: Tuberkulose im Erwachsenenalter
T Schaberg, T Bauer, F Brinkmann, R Diel, C Feiterna-Sperling, W Haas, ...
Pneumologie 71 (06), 325-397, 2017
Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia
ME Rutherford, R Ruslami, M Anselmo, B Alisjahbana, N Yulianti, ...
Bulletin of the World Health Organization 91, 932-941A, 2013
Standardized methods for enhanced quality and comparability of tuberculous meningitis studies
BJ Marais, AD Heemskerk, SS Marais, R van Crevel, U Rohlwink, M Caws, ...
Clinical Infectious Diseases 64 (4), 501-509, 2017
Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation
ME Rutherford, R Ruslami, W Maharani, I Yulita, S Lovell, R Van Crevel, ...
BMC research notes 5 (1), 7, 2012
Evaluation of high-versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis
R Ruslami, H Nijland, R Aarnoutse, B Alisjahbana, AY Soeroto, S Ewalds, ...
Antimicrobial agents and chemotherapy 50 (2), 822-823, 2006
The system can't perform the operation now. Try again later.
Articles 1–20